Cargando…
Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa
Resistance to carbapenems is a global threat, especially in developing countries with limited health resources. Prevalence, antibiogram, PCR detection of antibiotic resistance genes, and potency of Silver Nanoparticles (AgNPs) against multidrug-resistant (MDR) Pseudomonas aeruginosa were studied. Ki...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712613/ https://www.ncbi.nlm.nih.gov/pubmed/36450765 http://dx.doi.org/10.1038/s41598-022-24531-9 |
_version_ | 1784841825161314304 |
---|---|
author | Muddassir, Maria Raza, Almas Munir, Sadaf Basirat, Ahmad Ahmed, Muddassir Butt, Mazia Shahid Dar, Omair Arshad Ahmed, Syed Shoaib Shamim, Saba Naqvi, Syed Zeeshan Haider |
author_facet | Muddassir, Maria Raza, Almas Munir, Sadaf Basirat, Ahmad Ahmed, Muddassir Butt, Mazia Shahid Dar, Omair Arshad Ahmed, Syed Shoaib Shamim, Saba Naqvi, Syed Zeeshan Haider |
author_sort | Muddassir, Maria |
collection | PubMed |
description | Resistance to carbapenems is a global threat, especially in developing countries with limited health resources. Prevalence, antibiogram, PCR detection of antibiotic resistance genes, and potency of Silver Nanoparticles (AgNPs) against multidrug-resistant (MDR) Pseudomonas aeruginosa were studied. Kirby-Bauer disc method and PCR were used to study antibiogram and drug resistance genes respectively in 255 isolates of Pseudomonas aeruginosa obtained from a tertiary care hospital. Silver nitrate (AgNO(3)) precursor salts were reacted with Aspergillus flavus culture filtrate to trigger the extracellular mycosynthesis of AgNPs. Mycosynthesis was first monitored regularly by visible ultraviolet spectroscopy that recorded AgNP peaks of approximately 400–470 nm. Confirmation by Transmission electron micrographs provided confirmation of AgNPs formed within a range of 5–30 nm. Individual and combined antibacterial activity of ten antibiotics and AgNPs was analyzed. Pearson correlation coefficients (r) were calculated for phenotypic and genotypic multidrug resistance. Data were evaluated using SPSS version 20. p-value < 0.05 was considered statistically significant. 61.5% were carbapenemase producers (p < 0.01). The recorded frequency of bla(IMP-1), bla(SHV), bla(VIM), bla(OXA), and bla(TEM) were 13%, 32%, 15%, 21%, and 43%, respectively. The reducing order of antimicrobial activity of antibiotics and AgNPs was piperacillin/tazobactam + AgNPs (31 mm), cefoxitin + AgNPs (30 mm) > amikacin + AgNPs (25 mm) > aztreonam + AgNPs (23 mm) > meropenem + AgNPs (22 mm) > imipenem + AgNPs (20 mm) > gentamycin + AgNPs (17 mm) > ciprofloxacin + AgNPs (16 mm) > cefoperazone/sulbactam + AgNPs (14 mm) ≥ ceftazidime + AgNPs (14 mm). The conjugated effect of AgNPs plus antibiotics showed a 0.15–3.51 (average of 2.09) fold-area augmentation of antimicrobial activity. AgNPs conjugated with antibiotics effectively inhibited MDR Pseudomonas aeruginosa. To the best of our understanding, this is an inaugural report from Punjab Pakistan enlisting co-expression of Metallo-β-lactamases, extended-spectrum β-lactamases, and AmpC-β-lactamase plus activity of antibiotic-AgNPs. |
format | Online Article Text |
id | pubmed-9712613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97126132022-12-02 Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa Muddassir, Maria Raza, Almas Munir, Sadaf Basirat, Ahmad Ahmed, Muddassir Butt, Mazia Shahid Dar, Omair Arshad Ahmed, Syed Shoaib Shamim, Saba Naqvi, Syed Zeeshan Haider Sci Rep Article Resistance to carbapenems is a global threat, especially in developing countries with limited health resources. Prevalence, antibiogram, PCR detection of antibiotic resistance genes, and potency of Silver Nanoparticles (AgNPs) against multidrug-resistant (MDR) Pseudomonas aeruginosa were studied. Kirby-Bauer disc method and PCR were used to study antibiogram and drug resistance genes respectively in 255 isolates of Pseudomonas aeruginosa obtained from a tertiary care hospital. Silver nitrate (AgNO(3)) precursor salts were reacted with Aspergillus flavus culture filtrate to trigger the extracellular mycosynthesis of AgNPs. Mycosynthesis was first monitored regularly by visible ultraviolet spectroscopy that recorded AgNP peaks of approximately 400–470 nm. Confirmation by Transmission electron micrographs provided confirmation of AgNPs formed within a range of 5–30 nm. Individual and combined antibacterial activity of ten antibiotics and AgNPs was analyzed. Pearson correlation coefficients (r) were calculated for phenotypic and genotypic multidrug resistance. Data were evaluated using SPSS version 20. p-value < 0.05 was considered statistically significant. 61.5% were carbapenemase producers (p < 0.01). The recorded frequency of bla(IMP-1), bla(SHV), bla(VIM), bla(OXA), and bla(TEM) were 13%, 32%, 15%, 21%, and 43%, respectively. The reducing order of antimicrobial activity of antibiotics and AgNPs was piperacillin/tazobactam + AgNPs (31 mm), cefoxitin + AgNPs (30 mm) > amikacin + AgNPs (25 mm) > aztreonam + AgNPs (23 mm) > meropenem + AgNPs (22 mm) > imipenem + AgNPs (20 mm) > gentamycin + AgNPs (17 mm) > ciprofloxacin + AgNPs (16 mm) > cefoperazone/sulbactam + AgNPs (14 mm) ≥ ceftazidime + AgNPs (14 mm). The conjugated effect of AgNPs plus antibiotics showed a 0.15–3.51 (average of 2.09) fold-area augmentation of antimicrobial activity. AgNPs conjugated with antibiotics effectively inhibited MDR Pseudomonas aeruginosa. To the best of our understanding, this is an inaugural report from Punjab Pakistan enlisting co-expression of Metallo-β-lactamases, extended-spectrum β-lactamases, and AmpC-β-lactamase plus activity of antibiotic-AgNPs. Nature Publishing Group UK 2022-11-30 /pmc/articles/PMC9712613/ /pubmed/36450765 http://dx.doi.org/10.1038/s41598-022-24531-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Muddassir, Maria Raza, Almas Munir, Sadaf Basirat, Ahmad Ahmed, Muddassir Butt, Mazia Shahid Dar, Omair Arshad Ahmed, Syed Shoaib Shamim, Saba Naqvi, Syed Zeeshan Haider Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa |
title | Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa |
title_full | Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa |
title_fullStr | Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa |
title_full_unstemmed | Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa |
title_short | Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of Pseudomonas aeruginosa |
title_sort | antibacterial efficacy of silver nanoparticles (agnps) against metallo-β-lactamase and extended spectrum β-lactamase producing clinically procured isolates of pseudomonas aeruginosa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712613/ https://www.ncbi.nlm.nih.gov/pubmed/36450765 http://dx.doi.org/10.1038/s41598-022-24531-9 |
work_keys_str_mv | AT muddassirmaria antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT razaalmas antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT munirsadaf antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT basiratahmad antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT ahmedmuddassir antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT buttmaziashahid antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT daromairarshad antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT ahmedsyedshoaib antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT shamimsaba antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa AT naqvisyedzeeshanhaider antibacterialefficacyofsilvernanoparticlesagnpsagainstmetalloblactamaseandextendedspectrumblactamaseproducingclinicallyprocuredisolatesofpseudomonasaeruginosa |